Biotia
PrivateLast Round
Grant
Jun 17, 2025
Total Funding Raised
$10.4M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Biotia is a health technology company that provides sequencing-based technology and proprietary AI-powered software to identify microorganisms and antimicrobial resistance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical AI, Precision Medicine, Vertical SaaS
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biotia Comparables
Compare Biotia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pathogenomix, Inc. | 88% | |
| Noscendo GmbH | 84% | |
| BugSeq Bioinformatics Inc. | 83% |
Biotia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 17, 2025 | ||||
| Series A | Aug 23, 2022 | ||||
| Seed | Dec 10, 2019 |
Key People
Founding team and executive leadership
Biotia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Phoenix Venture Partners | Series A |
| SeedtoB Capital | Series A |
| Tau Ventures | Series A |
| SK Square Americas | Series A |
| DigitalDx Ventures | Series A |
| Continuum Health Ventures | Series A |
| SpringTide Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 123% MoM, reaching 5.6K.
- Apr 15, 2026
Monthly visitors increased 41% MoM, reaching 3.3K.
Biotia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Biotia's valuation, stock price, and market status.
Is Biotia a public or private company?
Biotia is a private company.
What is the current stock price of Biotia?
Biotia is a private company with no public stock price. No recent secondary market data is available.
How much is Biotia worth (valuation)?
Valuation information for Biotia is not publicly available.
Can I buy Biotia stock?
Biotia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Biotia's last funding round?
Biotia's most recent funding round was Series A on August 23, 2022.
Who are the main investors in Biotia?
Key investors in Biotia include OCA Ventures.
Will Biotia IPO soon?
No public IPO plans have been announced for Biotia.
How can I track Biotia secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Biotia's secondary market activity and sign up for updates.